Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mohammad-Kamran Derakhshan"'
Autor:
Ala Ghapanchi, Imaneh Abasi, Katharine A. Rimes, Maryam Bitarafan, Hamid Zarabi, Fatemeh Sara Derakhshan, Mohammad Kamran Derakhshan, Sepideh Ghanadanzadeh, Helena Whitley, Alireza Shamsi
Publikováno v:
Iranian Journal of Psychiatry, Vol 19, Iss 1 (2023)
Objective: This research is primarily conducted to determine the psychometric properties of the Beliefs about Emotions Scale (BES) in community and clinical samples. The BES is a scale measure used for evaluating individuals’ beliefs in terms of ho
Externí odkaz:
https://doaj.org/article/8086e3ae66a64933832c221ac7cf2568
Autor:
Mona Zamanian-Azodi, Mostafa Rezaei-Tavirani, Mohammad Mahboubi, Mohsen Hamidpour, Majid Rezaei Tavirani, Mostafa Hamdieh, Mohammad Rostami-Nejad, Naser Nejadi, Mohammad Kamran Derakhshan
Publikováno v:
Basic and Clinical Neuroscience, Vol 9, Iss 5, Pp 337-346 (2018)
Introduction: Many genetic studies are conducted on Obsessive-Compulsive Disorder (OCD). however, a high-throughput examination of proteome profile of this severe disease has not been performed yet. Methods: Here, the proteomic study of OCD patients
Externí odkaz:
https://doaj.org/article/4b44c13661e54843a7f7842e51ef1e08
Autor:
Mohammad Reza khodaei-Ardakani, Mohammad Kamran-Derakhshan, Omid Rezaei, Behrouz Dolatshahi, Arash Mirab-Zadeh
Publikováno v:
Journal of Rehabilitation, Vol 14, Iss 3, Pp 73-79 (2013)
Objective: There is evidence for differential executive function in Bipolar I Disorder (BID) and schizophrenia that may tend different cognitive deficits and abnormalities. The objective of this sudsy was to compare the executive function of BID and
Externí odkaz:
https://doaj.org/article/012b930027c242eaa3f314be1d7292b8
Autor:
Mona Zamanian-Azodi, Mohammad Mahboubi, Mohsen Hamidpour, Mostafa Rezaei-Tavirani, Mohammad Rostami-Nejad, Mohammad Kamran Derakhshan, Majid Rezaei Tavirani, Mostafa Hamdieh, Naser Nejadi
Publikováno v:
Basic and Clinical Neuroscience Journal. 9:337-346
Introduction Many genetic studies are conducted on Obsessive-Compulsive Disorder (OCD). however, a high-throughput examination of proteome profile of this severe disease has not been performed yet. Methods Here, the proteomic study of OCD patients' s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a595a5f819637a1bcb080e7ebc739790
https://doi.org/10.32598/bcn.9.5.337
https://doi.org/10.32598/bcn.9.5.337
Autor:
Mona Zamanian-Azodi, Mostafa Rezaei-Tavirani, Mohammad Mahboubi, Mohsen Hamidpour, Majid Rezaei Tavirani, Mostafa Hamdieh, Mohammad Rostami-Nejad, Naser Nejadi, Mohammad Kamran Derakhshan
Publikováno v:
Basic and Clinical Neuroscience
Basic and Clinical Neuroscience, Vol 9, Iss 5, Pp 337-346 (2018)
Basic and Clinical Neuroscience, Vol 9, Iss 5, Pp 337-346 (2018)
Introduction: Many genetic studies are conducted on Obsessive-Compulsive Disorder (OCD). however, a high-throughput examination of proteome profile of this severe disease has not been performed yet. Methods: Here, the proteomic study of OCD patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b9b54475fb65d3e49c43f3f5694ec6df
https://pubmed.ncbi.nlm.nih.gov/30719248
https://pubmed.ncbi.nlm.nih.gov/30719248
Autor:
Mona, Zamanian Azodi, Mostafa, Rezaei Tavirani, Afsaneh, Arefi Oskouie, Mostafa, Hamdieh, Mohammad Kamran, Derakhshan, Alireza, Ahmadzadeh, Farid, Zayeri, Naser, Nejadi, Majid, Rezaei Tavirani, Vahid, Mansouri, Mohammad, Rostami-Nejad, Reza, Vafaee
Publikováno v:
Iranian Journal of Pharmaceutical Research : IJPR
Obsessive-Compulsive Disorder (OCD) is one of the most common mental conditions. Proteome profiling may help identifying important proteins and finally shed lights to complexity of OCD underlying mechanisms. Here, by the application gel-based proteom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6fc0fbfb2a2f3a9cf467a1e356742c98
https://pubmed.ncbi.nlm.nih.gov/29201116
https://pubmed.ncbi.nlm.nih.gov/29201116
Autor:
Mohammad-Reza Khodaie-Ardakani, Ahmad Ali Noorbala, Mohammad Reza Mohammadi, Samarand Salimi, S. A. Ahmadi-Abhari, Mohammad-Kamran Derakhshan, Seyed Hesameddin Abbasi, Mohammad Hajiazim, Shahin Akhondzadeh, Akbar Fotouhi, Abolfazl Ghoreishi
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32:726-732
Impaired activity of the purinergic system is a plausible common factor that could be responsible for many aspects of schizophrenia. Based on purinegic hypothesis of schizophrenia, pharmacological treatments enhancing adenosine activity could be effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b66cd63f2f99067db71ee404df6bdb9
https://doi.org/10.1016/j.pnpbp.2007.11.021
https://doi.org/10.1016/j.pnpbp.2007.11.021
Autor:
Masoud, Mehrazin, Seyed Akbar, Nezameddini-Kachooei, Babak, Fallahi, Mohammad Kamran, Derakhshan, Davood, Beiki, Seyed Mohammad, Ghodsi, Majid, Assadi, Farzaneh, Pooyafard, Mohammad, Eftekhari
Publikováno v:
Hellenic journal of nuclear medicine. 14(3)
Our aim was to evaluate whether single photon emission tomography (SPET) versus computed tomography (CT) in acute phase of mild traumatic brain injury (MTBI) was better for the prediction of sustained neuropsychological symptoms beyond a typical reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ca604efb899e1a85129f55886dba34e5
https://pubmed.ncbi.nlm.nih.gov/22087443
https://pubmed.ncbi.nlm.nih.gov/22087443
Publikováno v:
Middle East Journal of Psychiatry and Alzheimers. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df14f7920bd047ca254018d2161aadda
https://doi.org/10.5742/mejpa.2011.21021
https://doi.org/10.5742/mejpa.2011.21021
Autor:
Afshar Amiri, Ali-Akbar Nejatisafa, Mohammad-Reza Khodaie-Ardakani, Mohammad Hajiazim, Mohammad-Kamran Derakhshan, Maedeh Raznahan, Ahmad Ali Noorbala, Abolfazl Ghoreishi, Shahin Akhondzadeh
Publikováno v:
Human psychopharmacology. 23(2)
Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI-B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7194a38befeca9d6dd28f07016a46c93
https://pubmed.ncbi.nlm.nih.gov/17972359
https://pubmed.ncbi.nlm.nih.gov/17972359